Title: Le rôle de la voie WNT dans l’homéostasie osseuse et ses dysrégulations
Novartis Institute for BioMedical Research
Michaela Kneissel is Global Head of the Musculoskeletal Disease Area (MSD) at the Novartis Institutes for BioMedical Research. MSD pursues the identification of therapies for muscle wasting and weakness, neuromuscular degeneration and inherent neuromuscular diseases, debilitating bone and mineral metabolism disorders as well as for tendon and joint repair.
Michaela Kneissel received her doctoral degree from the University of Vienna, Austria. She performed part of her Ph.D. work at the Hard Tissue Research Unit, University College London, UK and was postdoctoral fellow at the Radiobiology Division, University of Utah, Salt Lake City, USA before joining Novartis in 1996 where she has held positions of increasing responsibility. Michaela Kneissel currently serves on several scientific advisory and editorial boards and board of directors of societies and journals in the field of bone and mineral disorders.